RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2025 price target Incorrect.
The market cap did not grow more than 10x.
Roughly 4x increase - I'd even let you have 5x ... because I like you.
-----------
You would be hard press to make a good case for comparison.
A wise investor would know that PRN has been developing a single product since 2009 - it has been a very long road for initial seed investors. PRN was very risky and has been largely derisked due to FDA approval ... though ... it still doesn't have reimbursement.
GUD is a drug marketing company that licenses drugs mostly. It is a completely different beast that started from scratch just over 6 years ago.
----------
Hope that helps.